DR LALCHANDANI LABS LIMITED

Recent announcements

• The company due to ill health of the Chairman of the Company had filed the Application for extension of Annual General Meeting (AGM) for FY 2025-26, the ROC Delhi has considered and approved ....17 Sep 2026 · Company Update / General
• Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations for quarter ended June 202617 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Audited Financial Results for the quarter and year ended March 31, 20263 Jun 2026 · Board Meeting / Outcome of Board Meeting
• Audited Financial Results for the half year and year ended March 31, 22063 Jun 2026 · Result / Financial Results
• Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30, 2026.30 May 2026 · Company Update / Meeting Updates
• We are pleased to inform that the Company has successfully opened a new strategic Centre at Dwarka New Delhi.28 May 2026 · Company Update / General
• Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve financial results of the ....27 May 2026 · Board Meeting / Board Meeting
• <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....4 May 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
• <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
• Resignation of Mrs. Saniya Hussain from the position of Company Secretary and Compliance Officer22 Apr 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
• Reply to the clarification sought by exchange dated April 13, 202613 Apr 2026 · Company Update / General
• The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....13 Apr 2026 · Company Update / Clarification
• Certificate under Regulation 74(5) of SEBI DP Regulations for Quarter ended March 20269 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• Trading Window Closure for March 31, 202627 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
• post issue newspaper advertisements under Regulation 926 Mar 2026 · Company Update / Newspaper Publication
• The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuraag Gambhir5 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
• Approval of basis of allotment under Right issue2 Mar 2026 · Company Update / General
• Board meeting for approval of basis of allotment for right issue2 Mar 2026 · Others / Outcome without intimation
• Newspaper publication for extension of issue closing date and extension of date of on market renunciation of Rights Entitlements.17 Feb 2026 · Company Update / Newspaper Publication
• We wish to inform you that the Board of Directors of the Company considered and approved the extension of closing date of the ongoing right issue. The issue has been extended to February ....16 Feb 2026 · Company Update / General
• This is in reference to the 'Outcome of the Meeting of Board of Directors' dated January 20, 2026, we wish to inform you that the Board of Directors of Dr Lalchandani Labs Limited, at its ....16 Feb 2026 · Others / Outcome without intimation
• Corrigendum to the newspaper publication dated January 31, 20263 Feb 2026 · Company Update / Newspaper Publication
• Newspaper publication as per stated regulation31 Jan 2026 · Company Update / General
• Please find enclosed the soft copy of Letter of Offer dated January 20, 2026, for the Rights Issue of Dr Lalchandani Labs Limited. The Company is also submitting this Letter of Offer with ....21 Jan 2026 · Company Update / General
• ntimation of Record Date pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')20 Jan 2026 · Corp. Action / Record Date
• In continuation of our earlier intimation dated December 16, 2025, and subsequent deferment notice dated December 22, 2025, we wish to inform you that the meeting of the Board of Directors ....20 Jan 2026 · Company Update / Raising of Funds
• In continuation of our earlier intimation dated December 16, 2025, and subsequent deferment notice dated December 22, 2025, we wish to inform you that the meeting of the Board of Directors ....20 Jan 2026 · Company Update / General
• In continuation of our earlier intimation dated December 16, 2025, and subsequent deferment notice dated December 22, 2025, we wish to inform you that the meeting of the Board of Directors ....20 Jan 2026 · Others / Outcome without intimation
• We are pleased to inform that the company has received the In-principle approval from BSE Limited for Rights issue of Equity Shares, the letter is enclosed16 Jan 2026 · Company Update / General
• Compliance Certificate under Regulation 74(5) for Quarter ended December 31, 202512 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
• This is with reference to our prior intimation dated December 16, 2025, wherein we had informed the Exchange about the meeting of the Board of Directors of Dr Lalchandani Labs Limited ('the ....22 Dec 2025 · Board Meeting / Outcome of Board Meeting
• Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/12/2025 ,inter alia, to consider and approve fixation of the record ....16 Dec 2025 · Board Meeting / Board Meeting
• Board of Directors in the Board Meeting held today has approved the raising of fund by way of right issue to the eligible equity shareholders as on record date (to be determined and specified ....15 Dec 2025 · Company Update / Raising of Funds
• Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 433.31 Lakhs, to the eligible equity shareholders of ....15 Dec 2025 · Others / Outcome without intimation
• Outcome of Board Meeting9 Dec 2025 · Board Meeting / Outcome of Board Meeting
• Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2025 ,inter alia, to consider and approve raising of funds through ....2 Dec 2025 · Board Meeting / Board Meeting
• Unaudited Financial Results for the half year ended September 202514 Nov 2025 · Board Meeting / Outcome of Board Meeting
• Unaudited Financial results September 30, 202514 Nov 2025 · Result / Financial Results
• Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Financial Statements for ....10 Nov 2025 · Board Meeting / Board Meeting
• Certificate under Regulation 74(5) SEBI (DP) Regulation10 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018